Suspension of trading

Income Statement Hologic, Inc.

Stocks

HOLX

US4364401012

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2026-04-06 EDT			5-day change	1st Jan Change
76.01 ^USD	+0.48%		-.--%	+2.04%

09-24	Hologic, Inc. and Biotheranostics, Inc. Announce Updated Breast Cancer Index Test Report Option and Jama Network Open Data	CI
07-30	Quest Diagnostics And Hologic, Inc. Conduct National Health Trends Study On Bacterial Vaginosis And STI Co-Infection	CI

804.wqQLWes5aHsz0zvEVyqC0gVhSghPnd789BQlq-szAC0.kMN5HLlwOzB1oWmyMR_U4VwOPj0A1LHFhlhswIhKVX-B7kojokEHSHy7UA

Published financial data: HOLOGIC, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	5.63B	4.86B	4.03B	4.03B	4.1B
Total Revenues	5.63B	4.86B	4.03B	4.03B	4.1B
Cost of Goods Sold, Total	1.56B	1.55B	1.55B	1.58B	1.61B
Gross Profit	4.07B	3.31B	2.48B	2.45B	2.49B
Selling General & Admin Expenses, Total	972M	1.04B	995M	995M	994M
R&D Expenses	276M	283M	294M	273M	248M
Amortization of Goodwill and Intangible Assets - (IS)	319M	341M	234M	210M	191M
Other Operating Expenses	22.7M	-	-	-	-
Other Operating Expenses, Total	1.59B	1.66B	1.52B	1.48B	1.43B
Operating Income	2.49B	1.65B	958M	970M	1.06B
Interest Expense, Total	-93.6M	-95.1M	-111M	-122M	-117M
Interest And Investment Income	1.4M	12.9M	120M	109M	74.4M
Net Interest Expenses	-92.2M	-82.2M	9.4M	-13.4M	-42.7M
Income (Loss) On Equity Invest.	-	-	-	-3.6M	-9M
Currency Exchange Gains (Loss)	-17.1M	48.5M	-7.9M	-21M	11.6M
Other Non Operating Income (Expenses)	13.5M	-11.7M	6.2M	20.5M	7M
EBT, Excl. Unusual Items	2.39B	1.6B	966M	953M	1.03B
Restructuring Charges	-9.3M	-2.4M	-36.7M	-41.1M	-43M
Merger & Related Restructuring Charges	-2.3M	-	-	-	-77.9M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-1.8M	-8.3M	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-51.7M	-	-
Asset Writedown	-	-45.1M	-224M	-44.8M	-226M
In Process R&D Expenses	-	-	-	-	-
Insurance Settlements	-	2.4M	-	-	-
Legal Settlements	-	-	7.4M	-	-
Other Unusual Items	-14.9M	38.8M	14.9M	-1.7M	-
EBT, Incl. Unusual Items	2.36B	1.59B	676M	865M	681M
Income Tax Expense	491M	286M	220M	75.6M	116M
Earnings From Continuing Operations	1.87B	1.3B	456M	790M	566M
Net Income to Company	1.87B	1.3B	456M	790M	566M
Minority Interest	1.8M	-	-	-	-
Net Income - (IS)	1.87B	1.3B	456M	790M	566M
Net Income to Common Incl Extra Items	1.87B	1.3B	456M	790M	566M
Net Income to Common Excl. Extra Items	1.87B	1.3B	456M	790M	566M
Per Share Items
Net EPS - Basic	7.28	5.18	1.85	3.35	2.5
Basic EPS - Continuing Operations	7.28	5.18	1.85	3.35	2.5
Basic Weighted Average Shares Outstanding	257M	252M	247M	236M	226M
Net EPS - Diluted	7.21	5.13	1.83	3.32	2.49
Diluted EPS - Continuing Operations	7.21	5.13	1.83	3.32	2.49
Diluted Weighted Average Shares Outstanding	260M	254M	249M	238M	228M
Normalized Basic EPS	5.82	3.98	2.45	2.53	2.84
Normalized Diluted EPS	5.76	3.95	2.43	2.51	2.82
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	2.89B	2.08B	1.28B	1.27B	1.35B
EBITA	2.8B	1.99B	1.19B	1.18B	1.25B
EBIT	2.49B	1.65B	958M	970M	1.06B
EBITDAR	2.92B	2.11B	1.31B	1.31B	1.38B
Total Revenues (As Reported)	5.63B	4.86B	4.03B	4.03B	4.1B
Effective Tax Rate - (Ratio)	20.81	18.02	32.55	8.74	16.96
Current Domestic Taxes	538M	353M	296M	106M	217M
Current Foreign Taxes	23.2M	99M	32.7M	41.9M	39.7M
Total Current Taxes	562M	452M	329M	148M	257M
Deferred Domestic Taxes	-57.5M	-139M	-81.5M	-58.4M	-115M
Deferred Foreign Taxes	-12.6M	-26.9M	-27.6M	-13.7M	-26.5M
Total Deferred Taxes	-70.1M	-166M	-109M	-72.1M	-142M
Normalized Net Income	1.5B	1B	604M	595M	642M
Interest on Long-Term Debt	93.6M	95.1M	111M	122M	117M
Non-Cash Pension Expense	400K	4M	3.9M	3.5M	2.7M
Supplemental Operating Expense Items
Advertising Expense	9.8M	78.1M	31.4M	22.6M	24.7M
Selling and Marketing Expenses	561M	630M	595M	585M	569M
General and Administrative Expenses	410M	408M	400M	409M	424M
Research And Development Expense From Footnotes	564M	596M	680M	492M	608M
Net Rental Expense, Total	30.1M	28.6M	29.9M	41.3M	33.3M
Imputed Operating Lease Interest Expense	7.13M	7.15M	9.12M	14.51M	11.81M
Imputed Operating Lease Depreciation	22.97M	21.45M	20.78M	26.79M	21.49M
Stock-Based Comp., COGS (Total)	8M	9.1M	10.5M	10.7M	11.9M
Stock-Based Comp., R&D Exp. (Total)	7.7M	8.8M	10.5M	10.3M	8.2M
Stock-Based Comp., S&M Exp. (Total)	9.5M	10.5M	12M	13.4M	14.2M
Stock-Based Comp., G&A Exp. (Total)	38.9M	38.3M	46.6M	47.8M	50M
Stock-Based Comp., Other (Total)	900K	-	-	100K	-
Total Stock-Based Compensation	65M	66.7M	79.6M	82.3M	84.3M

Fiscal Period: September	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	1.17B	2.34B	2.72B	2.16B	1.96B
Short Term Investments	-	-	-	173M	243M
Trading Asset Securities, Total	-	31.9M	16.2M	3.1M	3.2M
Total Cash And Short Term Investments	1.17B	2.37B	2.74B	2.34B	2.21B
Accounts Receivable, Total	943M	618M	626M	600M	601M
Total Receivables	943M	618M	626M	600M	601M
Inventory	501M	624M	618M	680M	679M
Prepaid Expenses	527M	174M	151M	152M	147M
Other Current Assets, Total	27.4M	75.4M	51.9M	54.1M	34.8M
Total Current Assets	3.17B	3.86B	4.18B	3.82B	3.67B
Gross Property Plant And Equipment	1.34B	1.26B	1.29B	1.36B	1.45B
Accumulated Depreciation	-696M	-706M	-714M	-729M	-793M
Net Property Plant And Equipment	648M	550M	580M	630M	654M
Long-term Investments	9.5M	12.5M	26.2M	151M	78.5M
Goodwill	3.28B	3.24B	3.28B	3.44B	3.64B
Other Intangibles, Total	1.66B	1.28B	889M	845M	589M
Deferred Tax Assets Long-Term	21.9M	16.2M	56.6M	129M	240M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	131M	113M	122M	136M	145M
Total Assets	8.92B	9.07B	9.14B	9.16B	9.01B
Liabilities
Accounts Payable, Total	216M	198M	175M	204M	193M
Accrued Expenses, Total	482M	456M	452M	474M	478M
Current Portion of Long-Term Debt	313M	15M	287M	37.5M	2.9M
Current Portion of Leases	30.5M	26.4M	23.5M	27.3M	30.5M
Current Income Taxes Payable	70.9M	44.2M	62.3M	69.4M	72.8M
Unearned Revenue Current, Total	198M	186M	199M	213M	200M
Other Current Liabilities	16.3M	12M	8.2M	12.6M	-
Total Current Liabilities	1.33B	938M	1.21B	1.04B	977M
Long-Term Debt	2.72B	2.81B	2.53B	2.5B	2.5B
Long-Term Leases	88.9M	71.8M	62.4M	96.1M	88.4M
Unearned Revenue Non Current	20.3M	9.4M	13.8M	13.8M	12.4M
Pension & Other Post Retirement Benefits	10M	6.8M	-	-	-
Deferred Tax Liability Non Current	250M	90.8M	20.2M	59.4M	43.4M
Other Non Current Liabilities	285M	270M	288M	322M	341M
Total Liabilities	4.7B	4.2B	4.12B	4.03B	3.97B
Common Stock, Total	3M	3M	3M	3M	3M
Additional Paid In Capital	5.97B	6.04B	6.14B	6.24B	6.35B
Retained Earnings	298M	1.6B	2.06B	2.85B	3.41B
Treasury Stock	-1.99B	-2.53B	-3.04B	-3.85B	-4.61B
Comprehensive Income and Other	-59.1M	-238M	-148M	-112M	-101M
Total Common Equity	4.22B	4.88B	5.02B	5.13B	5.05B
Minority Interest	-	-	-	-	-
Total Equity	4.22B	4.88B	5.02B	5.13B	5.05B
Total Liabilities And Equity	8.92B	9.07B	9.14B	9.16B	9.01B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	251M	246M	240M	227M	223M
ECS Total Common Shares Outstanding	254M	247M	242M	232M	223M
Book Value / Share	16.63	19.73	20.76	22.14	22.68
Tangible Book Value	-722M	359M	847M	842M	818M
Tangible Book Value Per Share	-2.85	1.45	3.5	3.63	3.68
Total Debt	3.15B	2.92B	2.9B	2.66B	2.63B
Net Debt	1.98B	550M	165M	321M	421M
Debt Equivalent of Unfunded Proj. Benefit Obligation	10.3M	61.8M	65.4M	82.4M	92.4M
Debt Equivalent Oper. Leases	241M	229M	239M	330M	266M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	163M	253M	239M	251M	248M
Inventories - Work In Process, Total	53M	60.1M	66.3M	62M	68.4M
Inventories - Finished Goods, Total	285M	311M	313M	366M	363M
Land - (BS)	41.3M	40.9M	41.1M	40.8M	40.9M
Buildings, Total	191M	196M	230M	247M	256M
Machinery, Total	968M	898M	907M	926M	997M
Full Time Employees	6.7K	6.94K	6.99K	7.06K	7.07K
Accumulated Allowance for Doubtful Accounts (Supple)	40.5M	37.7M	38.5M	41.4M	38.2M
Order Backlog	-	-	-	-	-

Fiscal Period: September	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	1.87B	1.3B	456M	790M	566M
Depreciation & Amortization - CF	88M	89.2M	89.6M	92.1M	99.1M
Amortization of Goodwill and Intangible Assets - (CF)	319M	341M	234M	210M	191M
Depreciation & Amortization, Total	407M	430M	323M	302M	290M
(Gain) Loss From Sale Of Asset	-	-	51.7M	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	45.1M	224M	52M	236M
Stock-Based Compensation (CF)	65M	66.7M	79.6M	82.3M	84.3M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-26M	-172M	-95.1M	-24.5M	-98.2M
Change In Accounts Receivable	111M	272M	-1.5M	41M	7.8M
Change In Inventories	-84.1M	-137M	-4.9M	-47.4M	-1.3M
Change In Accounts Payable	20.4M	-14.4M	-23M	22.2M	-11.3M
Change in Unearned Revenues	14M	-12.3M	14.4M	9.3M	-15.3M
Change In Income Taxes	13M	-23.3M	17.4M	-21.7M	20.1M
Change in Other Net Operating Assets	-61.2M	368M	9.4M	80.7M	-20.4M
Cash from Operations	2.33B	2.13B	1.05B	1.29B	1.06B
Capital Expenditure	-156M	-127M	-150M	-130M	-137M
Cash Acquisitions	-1.16B	-159M	-5M	-297M	-322M
Divestitures	-	-	-	-31.3M	-
Sale (Purchase) of Intangible assets	-6.5M	-	-	-10M	-15.4M
Investment in Marketable and Equity Securities, Total	-	-	-10M	-310M	-5.9M
Other Investing Activities, Total	-2.2M	79.5M	13.1M	-2M	-2.9M
Cash from Investing	-1.33B	-206M	-152M	-781M	-483M
Short Term Debt Issued, Total	320M	-	-	-	-
Long-Term Debt Issued, Total	936M	1.49B	-	-	1.16B
Total Debt Issued	1.26B	1.49B	-	-	1.16B
Short Term Debt Repaid, Total	-322M	-248M	-	-	-
Long-Term Debt Repaid, Total	-1.05B	-1.46B	-19M	-291M	-1.2B
Total Debt Repaid	-1.37B	-1.7B	-19M	-291M	-1.2B
Issuance of Common Stock	51.3M	33.5M	43M	37.8M	38.8M
Repurchase of Common Stock	-457M	-565M	-499M	-852M	-775M
Other Financing Activities, Total	-10.4M	-12.2M	-8.4M	-2.6M	-1.1M
Cash from Financing	-530M	-756M	-483M	-1.11B	-777M
Foreign Exchange Rate Adjustments	-1.7M	5.8M	300K	8.9M	2.1M
Net Change in Cash	469M	1.17B	416M	-596M	-201M
Supplemental Items
Cash Interest Paid	93.2M	99.7M	105M	117M	113M
Cash Income Tax Paid (Refund)	615M	36.2M	296M	138M	224M
Levered Free Cash Flow	1.42B	1.77B	828M	809M	808M
Unlevered Free Cash Flow	1.48B	1.83B	897M	885M	881M
Change In Net Working Capital	383M	-432M	-45.3M	-34.8M	4.2M
Net Debt Issued / Repaid	-113M	-212M	-19M	-291M	-39.8M

Fiscal Period: September	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	19.28	11.45	6.58	6.63	7.3
Return on Total Capital	23.45	13.57	7.62	7.72	8.58
Return On Equity %	53.99	28.63	9.22	15.56	11.12
Return on Common Equity	54.06	28.63	9.22	15.56	11.12
Margin Analysis
Gross Profit Margin %	72.35	68.08	61.57	60.73	60.82
SG&A Margin	17.25	21.35	24.69	24.68	24.23
EBITDA Margin %	51.35	42.74	31.8	31.56	32.95
EBITA Margin %	49.79	40.9	29.58	29.28	30.53
EBIT Margin %	44.12	33.89	23.78	24.07	25.88
Income From Continuing Operations Margin %	33.2	26.77	11.31	19.59	13.8
Net Income Margin %	33.23	26.77	11.31	19.59	13.8
Net Avail. For Common Margin %	33.23	26.77	11.31	19.59	13.8
Normalized Net Income Margin	26.55	20.6	14.98	14.77	15.67
Levered Free Cash Flow Margin	25.23	36.44	20.53	20.07	19.7
Unlevered Free Cash Flow Margin	26.27	37.67	22.26	21.96	21.48
Asset Turnover
Asset Turnover	0.7	0.54	0.44	0.44	0.45
Fixed Assets Turnover	9.23	8.11	7.13	6.66	6.39
Receivables Turnover (Average Receivables)	5.71	6.23	6.48	6.57	6.83
Inventory Turnover (Average Inventory)	3.48	2.76	2.5	2.44	2.36
Short Term Liquidity
Current Ratio	2.39	4.12	3.47	3.69	3.75
Quick Ratio	1.59	3.19	2.79	2.83	2.87
Operating Cash Flow to Current Liabilities	1.76	2.27	0.87	1.24	1.08
Days Sales Outstanding (Average Receivables)	63.71	58.4	57.22	55.36	53.31
Days Outstanding Inventory (Average Inventory)	104.74	131.89	148.65	149.18	153.96
Average Days Payable Outstanding	43.18	44.95	44.83	41.93	45
Cash Conversion Cycle (Average Days)	125.26	145.34	161.04	162.61	162.27
Long Term Solvency
Total Debt/Equity	74.72	59.92	57.89	51.81	52.04
Total Debt / Total Capital	42.77	37.47	36.66	34.13	34.23
LT Debt/Equity	66.58	59.07	51.7	50.55	51.38
Long-Term Debt / Total Capital	38.11	36.94	32.74	33.3	33.79
Total Liabilities / Total Assets	52.71	46.25	45.11	43.97	44
EBIT / Interest Expense	26.55	17.33	8.63	7.95	9.06
EBITDA / Interest Expense	31.22	22.15	11.81	10.76	11.82
(EBITDA - Capex) / Interest Expense	29.55	20.82	10.45	9.69	10.65
Total Debt / EBITDA	1.08	1.39	2.21	2.02	1.9
Net Debt / EBITDA	0.68	0.26	0.13	0.24	0.3
Total Debt / (EBITDA - Capex)	1.14	1.48	2.5	2.25	2.11
Net Debt / (EBITDA - Capex)	0.72	0.28	0.14	0.27	0.34
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	49.14	-13.66	-17.12	-0	1.74
Gross Profit, 1 Yr. Growth %	62.13	-18.71	-25.04	-0.37	1.89
EBITDA, 1 Yr. Growth %	88.58	-28.08	-38.33	1.19	6.83
EBITA, 1 Yr. Growth %	93.32	-29.01	-40.07	1.07	6.77
EBIT, 1 Yr. Growth %	114.69	-33.62	-41.86	3.92	9.37
Earnings From Cont. Operations, 1 Yr. Growth %	68.37	-30.36	-64.98	73.14	-28.35
Net Income, 1 Yr. Growth %	67.82	-30.43	-64.98	73.14	-28.35
Normalized Net Income, 1 Yr. Growth %	125.94	-32.94	-39.73	1.21	7.9
Diluted EPS Before Extra, 1 Yr. Growth %	71.26	-28.85	-64.33	81.42	-25
Accounts Receivable, 1 Yr. Growth %	-8.38	-34.49	1.3	-4.03	0.07
Inventory, 1 Yr. Growth %	26.85	24.44	-0.98	10.07	-0.06
Net Property, Plant and Equip., 1 Yr. Growth %	13.3	-15.09	5.3	8.68	3.76
Total Assets, 1 Yr. Growth %	23.96	1.7	0.75	0.18	-1.54
Tangible Book Value, 1 Yr. Growth %	-42.69	-149.72	135.87	-0.55	-2.86
Common Equity, 1 Yr. Growth %	55.94	15.59	2.89	2.25	-1.6
Cash From Operations, 1 Yr. Growth %	159.92	-8.78	-50.55	22.26	-17.75
Capital Expenditures, 1 Yr. Growth %	-0.13	-28.42	18.08	-13.32	5.22
Levered Free Cash Flow, 1 Yr. Growth %	98.6	27.76	-53.3	-0.42	0.78
Unlevered Free Cash Flow, 1 Yr. Growth %	87.68	26.7	-51.03	0.39	0.35
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.33	13.48	-15.41	-8.96	0.87
Gross Profit, 2 Yr. CAGR %	40.37	14.92	-21.94	-14.02	0.75
EBITDA, 2 Yr. CAGR %	67.46	16.67	-33.4	-21.77	3.37
EBITA, 2 Yr. CAGR %	72.83	17.38	-34.77	-22.98	3.23
EBIT, 2 Yr. CAGR %	109.14	19.68	-37.87	-23.28	6.19
Earnings From Cont. Operations, 2 Yr. CAGR %	203.04	8.28	-50.61	-22.13	11.38
Net Income, 2 Yr. CAGR %	203.18	8.05	-50.64	-22.13	11.38
Normalized Net Income, 2 Yr. CAGR %	134.48	23.24	-36.4	-22.86	4.1
Diluted EPS Before Extra, 2 Yr. CAGR %	208.01	10.39	-49.62	-19.55	16.65
Accounts Receivable, 2 Yr. CAGR %	20.55	-22.52	-18.54	-1.4	-2
Inventory, 2 Yr. CAGR %	6.14	25.64	11.01	4.4	4.88
Net Property, Plant and Equip., 2 Yr. CAGR %	17.33	-1.91	-5.44	6.98	6.19
Total Assets, 2 Yr. CAGR %	17.67	12.28	1.22	0.47	-0.68
Tangible Book Value, 2 Yr. CAGR %	-38.47	-46.62	8.3	53.15	-1.71
Common Equity, 2 Yr. CAGR %	41.21	34.26	9.05	2.57	0.31
Cash From Operations, 2 Yr. CAGR %	89.42	53.98	-32.84	-22.24	0.28
Capital Expenditures, 2 Yr. CAGR %	19.65	-9.82	-8.06	1.17	-4.5
Levered Free Cash Flow, 2 Yr. CAGR %	63.19	57.84	-22.76	-32.45	-0.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	54.28	52.83	-21.23	-30.49	-0.3
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	20.51	13.03	2.19	-10.56	-5.52
Gross Profit, 3 Yr. CAGR %	26.43	16.98	-0.33	-15.61	-9.01
EBITDA, 3 Yr. CAGR %	43.03	26.31	-5.67	-23.93	-13.37
EBITA, 3 Yr. CAGR %	46.78	28.44	-6.18	-25.04	-14.3
EBIT, 3 Yr. CAGR %	69.76	42.62	-5.92	-26.89	-13.65
Earnings From Cont. Operations, 3 Yr. CAGR %	156.11	85.61	-25.67	-24.98	-24.26
Net Income, 3 Yr. CAGR %	156.19	85.61	-25.78	-25	-24.26
Normalized Net Income, 3 Yr. CAGR %	85.76	54.44	-2.9	-26.39	-13.73
Diluted EPS Before Extra, 3 Yr. CAGR %	161.2	88.99	-24.25	-22.78	-21.41
Accounts Receivable, 3 Yr. CAGR %	17.63	-1.62	-15.28	-13.96	-0.92
Inventory, 3 Yr. CAGR %	9.28	11.92	16.06	10.69	2.89
Net Property, Plant and Equip., 3 Yr. CAGR %	10.68	5.34	0.44	-0.95	5.89
Total Assets, 3 Yr. CAGR %	7.25	12.08	8.3	0.87	-0.21
Tangible Book Value, 3 Yr. CAGR %	-33.92	-42.69	-12.4	5.26	31.59
Common Equity, 3 Yr. CAGR %	20.21	32.09	22.86	6.74	1.16
Cash From Operations, 3 Yr. CAGR %	47.05	48.47	5.45	-17.99	-20.77
Capital Expenditures, 3 Yr. CAGR %	13.94	5.25	-1.34	-9.85	2.5
Levered Free Cash Flow, 3 Yr. CAGR %	30.72	49.2	5.18	-16.46	-23.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	26.6	43.36	4.59	-15.09	-21.65
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	14.74	9.72	4.61	3.66	1.66
Gross Profit, 5 Yr. CAGR %	17.02	11.08	4.24	3.43	-0.1
EBITDA, 5 Yr. CAGR %	22.92	15.93	5.34	4.28	-2.42
EBITA, 5 Yr. CAGR %	24.22	17.03	6.1	4.68	-2.81
EBIT, 5 Yr. CAGR %	34.18	24.71	13.53	11.29	-1.61
Earnings From Cont. Operations, 5 Yr. CAGR %	41.4	11.5	32.58	31.13	-12.62
Net Income, 5 Yr. CAGR %	41.42	11.5	32.58	31.13	-12.69
Normalized Net Income, 5 Yr. CAGR %	41.66	31.72	20.95	16.97	-0.52
Diluted EPS Before Extra, 5 Yr. CAGR %	44.11	14.21	35.24	34.3	-9.97
Accounts Receivable, 5 Yr. CAGR %	16.09	2.97	1.55	-1.54	-10.2
Inventory, 5 Yr. CAGR %	12.78	13.47	9.96	8.85	11.45
Net Property, Plant and Equip., 5 Yr. CAGR %	7.09	3.09	3.92	5.99	2.7
Total Assets, 5 Yr. CAGR %	4.04	2.6	4.8	7.28	4.61
Tangible Book Value, 5 Yr. CAGR %	-26.27	-35.27	-19.48	-15.08	-8.28
Common Equity, 5 Yr. CAGR %	14.51	11.86	15.61	19.38	13.29
Cash From Operations, 5 Yr. CAGR %	23.9	203.17	7.48	14.62	3.35
Capital Expenditures, 5 Yr. CAGR %	10.57	3.4	7.3	3.6	-2.61
Levered Free Cash Flow, 5 Yr. CAGR %	13.93	24.08	5.4	8.67	2.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.06	21.27	4.23	7.32	2.35